The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Caroline Berube
Hematologist
Clinical Associate Professor, Medicine - Hematology
- 875 Blake Wilbur Drive
- Clinic C
- Palo Alto, CA 94304
- Phone: 650-498-6000
- 900 Blake Wilbur Drive
- 2nd Floor, Room W2081
- Palo Alto, CA 94304
- Phone: 650-725-4932
Practice Areas
Professional Education
- Board Certification: Medical Oncology, Royal College of Physicians and Surgeons of Canada (1990)
- Board Certification: Hematology, Royal College of Physicians and Surgeons (1989)
- Board Certification: Internal Medicine, Royal College of Physicians and Surgeons of Canada (1988)
- Residency: Laval University (1987) Canada
- Internship: Laval University (1984) Canada
- Fellowship: McMaster University (1991) Canada
- Fellowship: The University of British Columbia (1990) Canada
- Oncology, University of BC, Canada, Medical Oncology (1990)
- Board certification, Hematology, Canadian Hematology Board (1989)
- Fellowship: University of Montreal (1989) Canada
- Hematology, University of Montreal, Canada, Hematology (1989)
- Medical Education: Laval University (1983) Canada
- F.R.C.P.(C), Internal Medicine, Canadian Board (1987)
- M.D., Laval University, Canada, Medicine (1984)
Administrative Appointments
- Medical Director, Oral Anticoagulation Clinic, Stanford Hospital and Clinics (2004 - Present)
Publications
-
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome.
Narayan, R., Garcia, J. S., Percival, M.-E. M., Berube, C., Coutre, S., & Medeiros, B. C. (2016). Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome. Leukemia & lymphoma, 57(3), 609-615. -
Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome
Zikos, T. A., Sokolove, J., Ahuja, N., & Berube, C. (2015). Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 21(6), 311-313. -
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia.
Liedtke, M., Dunn, T., Dinner, S., Coutré, S. E., Berube, C., & Medeiros, B. (2014). Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia. Leukemia research, 38(12), 1441-1445. -
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Pollyea, D. A., Zehnder, J., Coutre, S., Gotlib, J. R., Gallegos, L., & Medeiros, B. C. (2013). Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia. HAEMATOLOGICA, 98(4), 591-596.
-
Accessory splenules in autoimmune hemolytic anemia.
Logan, A., Berube, C., & Gotlib, J. (2013). Accessory splenules in autoimmune hemolytic anemia. American journal of hematology, 88(2), 156-?.
-
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
Pollyea, D. A., Kohrt, H. E., Gallegos, L., Figueroa, M. E., Abdel-Wahab, O., & Medeiros, B. C. (2012). Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. LEUKEMIA, 26(5), 893-901.
-
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
Liedtke, M., Twist, C. J., Medeiros, B. C., Gotlib, J. R., Berube, C., & Coutre, S. E. (2012). Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 97(1), 30-37.
-
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer
Lee, R., Wen, A., & Berube, C. (2011). Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 68(9), 814-817.
-
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience
Kohrt, H. E., Patel, S., Ho, M., Owen, T., Pollyea, D. A., & Medeiros, B. C. (2010). Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience. AMERICAN JOURNAL OF HEMATOLOGY, 85(11), 877-881.
-
Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9
Sagrieya, H., Berube, C., Wen, A., Ramakrishnan, R., Mir, A., & Altman, R. B. (2010). Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. PHARMACOGENETICS AND GENOMICS, 20(7), 407-413.
-
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
Gotlib, J., Berube, C., Growney, J. D., Chen, C. C., George, T. I., & Coutre, S. E. (2005). Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. BLOOD, 106(8), 2865-2870.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Jun 2016
Both Dr. Berube and the resident were very informed and helped me come up with a good care plan.
SHC Patient, May 2016
The providers, Dr's, nurses, PA's etc are substantially better than the facility clinic than I usually attend. It is a night and day comparison.
SHC Patient, Apr 2016
Dr. Berube was excellent. Answered all of my questions thoroughly, really took the time to explain my condition in a way I understood.
SHC Patient, Apr 2016
Dr. Berube ALWAYS greets me with a smile and takes excellent care of me!
SHC Patient, Apr 2016
Love Dr. Berube.
SHC Patient, Mar 2016
Both doctors took all the time I needed an were clearly concerned to help resolve the worries of my wife and I.
SHC Patient, Mar 2016
Good.
SHC Patient, Feb 2016
Very thorough.
SHC Patient, Jan 2016
Dr. Berube is amazing!
SHC Patient, Nov 2015
Dr. Berube was excellent in every way -
SHC Patient, Sep 2015
Everything was good.
SHC Patient, Aug 2015
Dr. Berube has always made me feel incredibly comfortable to share any concern or question.
SHC Patient, Jul 2015
I had many questions & concerns during my visit. Dr. Berube took a lot of time with me & did not rush me.
SHC Patient, May 2015
Excellent!
SHC Patient, Mar 2015
I have seen many hematologists, and none compare to Dr. Berube. She's great!
SHC Patient, Nov 2014
Dr. Caroline Berube even her telling me about my weight, give me the power and I will not let her down.
SHC Patient, Oct 2014
You need a spot here for EXCELLENT because to call Dr. Berube' "very good" is negligent - she saved my life from AML and I am forever in her debt.
SHC Patient, Oct 2014
Dr. Berube has big a huge part of my recovery.
SHC Patient, Sep 2014
Dr. Berube went above & beyond to help me get the medication I needed & even personally called the insurance company to help make sure it was covered.
SHC Patient, Aug 2014
Dr. Berube has the patience of a saint. Very cautious and concerned. ALWAYS answers my endless list of questions. Worked hard to get me into NIH trial!
SHC Patient, Jul 2014
Dr. Berube is wonderful physician, kind, thoughtful, helpful.
SHC Patient, Jun 2014
If anyone I know needed this type of doctor I would INSIST that they see Dr. Berube.
SHC Patient, May 2014
Doctor Berube was all business not very personable at all nor very friendly. Her assistant was much more friendly and seemed more concerned about my health then her.
SHC Patient, May 2014
Dr. Berube is an exceptional care provider.
SHC Patient, Jun 2016
Both Dr. Berube and the resident were very informed and helped me come up with a good care plan.
SHC Patient, May 2016
The providers, Dr's, nurses, PA's etc are substantially better than the facility clinic than I usually attend. It is a night and day comparison.
SHC Patient, Apr 2016
Dr. Berube was excellent. Answered all of my questions thoroughly, really took the time to explain my condition in a way I understood.
SHC Patient, Apr 2016
Dr. Berube ALWAYS greets me with a smile and takes excellent care of me!
SHC Patient, Apr 2016
Love Dr. Berube.
SHC Patient, Mar 2016
Both doctors took all the time I needed an were clearly concerned to help resolve the worries of my wife and I.
SHC Patient, Mar 2016
Good.
SHC Patient, Feb 2016
Very thorough.
SHC Patient, Jan 2016
Dr. Berube is amazing!
SHC Patient, Nov 2015
Dr. Berube was excellent in every way -
SHC Patient, Sep 2015
Everything was good.
SHC Patient, Aug 2015
Dr. Berube has always made me feel incredibly comfortable to share any concern or question.
View All 24 Patient Comments »